This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Pennsylvania. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Marjaneh Razmara: Innovator in Cancer Treatment
Introduction
Marjaneh Razmara is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of fusion proteins. With a total of 2 patents, her work focuses on addressing critical health challenges, particularly in autoimmune diseases and cancer.
Latest Patents
Marjaneh Razmara's latest patents include the development of Fn14/TRAIL fusion proteins and methods for treating cancer. These fusion proteins act on the TWEAK and TRAIL signaling axes, providing a novel approach to the treatment and amelioration of autoimmune diseases, especially multiple sclerosis. Additionally, these proteins are beneficial in addressing other diseases, including alloimmune diseases and cancer.
Career Highlights
Marjaneh Razmara has established herself as a key figure in her field, working at the University of Pennsylvania. Her research has garnered attention for its potential impact on therapeutic strategies for complex diseases. Her dedication to innovation and scientific advancement is evident in her work and contributions to the medical community.
Collaborations
Marjaneh collaborates with notable professionals in her field, including her coworker Mark L Tykocinski. These collaborations enhance the research efforts and broaden the scope of their innovative projects.
Conclusion
Marjaneh Razmara's contributions to cancer treatment through her patented fusion proteins exemplify her commitment to advancing medical science. Her work not only addresses pressing health issues but also paves the way for future innovations in the treatment of autoimmune diseases and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile